Steris plc stock edges lower as technicals turn bearish

Steris plc stock (ISIN IE00BFY8C754) closed near USD 209 on its US listing on September 17, 2026, marking a modest decline compared with the prior session while the broader S&P 500 rose 1.1 percent on the same date.

Stock trails the index as sentiment cools

According to Ad-hoc-news, Steris plc stock traded around USD 209 on September 17, 2026 on its primary US listing, with intraday data from Yahoo Finance showing a level of USD 208.64, down USD 1.26 or 0.60 percent in that session.

The same overview notes that the S&P 500 closed at 7,637.76 points on September 17, 2026, up 1.1 percent, which means Steris plc stock lagged the benchmark index by roughly 1.7 percentage points on that trading day.

Bearish technical picture with oversold signals

Fresh technical analysis data from Moneycontrol as of September 18, 2026 classify the overall trend in Steris plc stock as very bearish based on a combination of moving averages and technical indicators.

In that daily technical overview, the 14-day relative strength index (RSI) for Steris stands at 27.08, which places the shares in oversold territory below the commonly watched threshold of 30.

The same Moneycontrol data set show the stochastic oscillator (20,3) at 1.85 and the Williams %R(14) at minus 97.87, both consistent with an oversold reading for Steris plc stock on a short-term basis as of September 18, 2026.

Alongside these readings, the report points to a 20-day rate-of-change (ROC) of minus 12.19 for Steris, signaling that the stock price has declined by about 12.19 percent over that 20-day look-back period.

Average true range (ATR) over 14 days is listed at 5.15, categorized as low volatility in the Moneycontrol overview, indicating that the recent moves in Steris have come with relatively contained daily price swings despite the downward bias.

Key technical levels investors are watching

The same daily technical page calculates classic pivot-point levels for Steris plc stock, with a central pivot at USD 210.58, first resistance (R1) at USD 212.56 and first support (S1) at USD 207.68 as of September 18, 2026.

Further out, the classic second resistance (R2) is pegged at USD 215.46 and second support (S2) at USD 205.70, while the Fibonacci-based levels place R1 at USD 212.44 and S1 at USD 208.72.

Moneycontrol also lists the upper Bollinger Band at USD 246.30 and the lower band at USD 203.12 around a 20-day simple moving average of USD 224.71, which frames the recent trading range for Steris within a broader volatility channel.

In terms of relative performance, the six-month relative strength comparison (RSC) score for Steris is cited at 84.4, described as underperformer status, indicating that Steris plc stock has underperformed its reference group over the past six months.

Market context and valuation backdrop

The earlier corporate-news coverage from Ad-hoc-news notes that price overviews in mid September valued Steris near USD 21,000,000,000 in market capitalization when the stock was trading in the low USD 200s on its US listing.

That implied valuation level places Steris among the larger mid-cap to lower large-cap names in the US healthcare and medical technology space, giving the stock a profile that can attract institutional investors focused on defensive growth.

The same Ad-hoc-news article highlights that on September 17, 2026 Steris plc stock moved slightly lower in price terms even as the S&P 500 recorded a solid gain, underlining how defensive healthcare names can sometimes trade differently from the broader index when sector-specific factors dominate sentiment.

Closing price and recent performance

Based on the latest available closing data referenced by Ad-hoc-news for September 17, 2026, Steris plc stock ended that US session at about USD 209 on its primary US listing, with an intraday indication of USD 208.64 that represented a decline of 0.60 percent compared with the previous close.

More news and analyses on Steris plc stock